Answers are grounded in this paper and cite their sources.
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has become a standard surgical treatment option for Parkinson's disease.However, STN-DBS can cause mood-related side effects such as depression.Previous studies have shown that the inhibition of serotonergic cells in the dorsal raphe nucleus (DRN) is a potential cause of depressive-like behavior in rodents treated with STN-DBS.However, the exact anatomical circuitry behind this effect remains elusive.Given the absence of a direct anatomical connection between the STN and the DRN, relay nuclei such as the lateral habenula have been proposed to mediate those effects.Novel cell-type-specific viral tracing methods have recently unveiled a new connection from the STN to the DRN via the globus pallidus externa (GPe).To investigate whether this newly discovered anatomical connection relays the inhibitory effect of STN-DBS to the DRN, we used the designer receptors exclusively activated by the designer drug (DREADD) to inhibit the GPe.We utilized a cell-type-specific calcium indicator in transgenic 5-HT-Cre (ePet-Cre) mice to assess the activity of serotonergic cells in the DRN in STN-DBS mice while the GPe was challenged with DREADD.We observed that chemogenetic modulation of the GPe does not interfere with the suppression of DRN 5-HT neuronal activity caused by STN-DBS.These results suggest that the GPe may not serve as a relay for transmitting the suppressive effects of STN-DBS to the serotonergic neurons in the DRN or the DREADD modulation on the GPe was insufficient to counteract the effects of DBS in our study.
No takes yet. Share an insight, caveat, or question.
Alosaimi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: